0001104659-22-034156.txt : 20220316 0001104659-22-034156.hdr.sgml : 20220316 20220316060418 ACCESSION NUMBER: 0001104659-22-034156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220314 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brady James Aloysius CENTRAL INDEX KEY: 0001916987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 22743217 MAIL ADDRESS: STREET 1: C/O VERONA PHARMA PLC STREET 2: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm229323-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-03-14 0 0001657312 Verona Pharma plc VRNA 0001916987 Brady James Aloysius 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 1 0 0 0 Share Options (Right to Buy) 0.6025 2022-03-14 4 A 0 288000 0 A 2032-03-13 Ordinary Shares 288000 288000 D The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. The option vests and becomes exercisable as to 25% on August 1, 2022, 25% on November 1, 2022, 25% on February 1, 2023 and 25% on May 1, 2023. /s/ Claire Poll, Attorney-in-fact for James Aloysius Brady 2022-03-16